» Articles » PMID: 35104285

Tracking Changes Between Preprint Posting and Journal Publication During a Pandemic

Overview
Journal PLoS Biol
Specialty Biology
Date 2022 Feb 1
PMID 35104285
Authors
Affiliations
Soon will be listed here.
Abstract

Amid the Coronavirus Disease 2019 (COVID-19) pandemic, preprints in the biomedical sciences are being posted and accessed at unprecedented rates, drawing widespread attention from the general public, press, and policymakers for the first time. This phenomenon has sharpened long-standing questions about the reliability of information shared prior to journal peer review. Does the information shared in preprints typically withstand the scrutiny of peer review, or are conclusions likely to change in the version of record? We assessed preprints from bioRxiv and medRxiv that had been posted and subsequently published in a journal through April 30, 2020, representing the initial phase of the pandemic response. We utilised a combination of automatic and manual annotations to quantify how an article changed between the preprinted and published version. We found that the total number of figure panels and tables changed little between preprint and published articles. Moreover, the conclusions of 7.2% of non-COVID-19-related and 17.2% of COVID-19-related abstracts undergo a discrete change by the time of publication, but the majority of these changes do not qualitatively change the conclusions of the paper.

Citing Articles

The academic impact of Open Science: a scoping review.

Klebel T, Traag V, Grypari I, Stoy L, Ross-Hellauer T R Soc Open Sci. 2025; 12(3):241248.

PMID: 40046663 PMC: 11879623. DOI: 10.1098/rsos.241248.


Predicting the replicability of social and behavioural science claims in COVID-19 preprints.

Marcoci A, Wilkinson D, Vercammen A, Wintle B, Abatayo A, Baskin E Nat Hum Behav. 2024; 9(2):287-304.

PMID: 39706868 PMC: 11860236. DOI: 10.1038/s41562-024-01961-1.


The evolution and adaptation of evidence synthesis during the COVID-19 pandemic in Canada: Perspectives of evidence synthesis producers.

Corrin T, Kennedy E PLoS One. 2024; 19(11):e0314657.

PMID: 39602442 PMC: 11602041. DOI: 10.1371/journal.pone.0314657.


Preprint pointers from a long COVID scoping review: considerations for source selection and searching.

McGill S J Can Health Libr Assoc. 2024; 45(2):88-97.

PMID: 39430651 PMC: 11485164. DOI: 10.29173/jchla29741.


Public understanding of preprints: How audiences make sense of unreviewed research in the news.

Fleerackers A, Ratcliff C, Wicke R, King A, Jensen J Public Underst Sci. 2024; 34(2):154-171.

PMID: 39392727 PMC: 11783973. DOI: 10.1177/09636625241268881.


References
1.
Sheldon T . Preprints could promote confusion and distortion. Nature. 2018; 559(7715):445. DOI: 10.1038/d41586-018-05789-4. View

2.
Vale R . Accelerating scientific publication in biology. Proc Natl Acad Sci U S A. 2015; 112(44):13439-46. PMC: 4640799. DOI: 10.1073/pnas.1511912112. View

3.
Zhu N, Zhang D, Wang W, Li X, Yang B, Song J . A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020; 382(8):727-733. PMC: 7092803. DOI: 10.1056/NEJMoa2001017. View

4.
Abdill R, Blekhman R . Tracking the popularity and outcomes of all bioRxiv preprints. Elife. 2019; 8. PMC: 6510536. DOI: 10.7554/eLife.45133. View

5.
Eisen M, Akhmanova A, Behrens T, Weigel D . Publishing in the time of COVID-19. Elife. 2020; 9. PMC: 7096178. DOI: 10.7554/eLife.57162. View